MorphoSys
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MorphoSys and other ETFs, options, and stocks.About MOR
MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat.
CEOJean-Paul Kress
CEOJean-Paul Kress
Employees564
Employees564
HeadquartersPlanegg, Bayern (Bavaria)
HeadquartersPlanegg, Bayern (Bavaria)
Founded1992
Founded1992
Employees564
Employees564
MOR Key Statistics
Market cap2.73B
Market cap2.73B
Price-Earnings ratio-11.74
Price-Earnings ratio-11.74
Dividend yield—
Dividend yield—
Average volume412.93K
Average volume412.93K
High today$18.16
High today$18.16
Low today$18.10
Low today$18.10
Open price$18.15
Open price$18.15
Volume274.03K
Volume274.03K
52 Week high$18.31
52 Week high$18.31
52 Week low$3.89
52 Week low$3.89
MOR News
TipRanks 1d
MorphoSys AG Reports Major Shareholding Changes - TipRanks.com - TipRanksMorphosys (MOR) has released an update. MorphoSys AG has announced a significant change in their major shareholdings, with DWS Investment GmbH’s voting rights...
Yahoo Finance 7d
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act - Yahoo FinancePLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 22, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced the receipt of U.S. antitrust clearance under the...
Analyst ratings
70%
of 10 ratingsBuy
30%
Hold
70%
Sell
0%